STOCKHOLDERS' EQUITY (Tables)

9 Months Ended

Sep. 30, 2020

A summary of Stock-based compensation expense recognized is presented below:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Stock-based compensation	$	1,875	$	147,570	$	76,154	$	343,824

Common Share Equivalent Excluded from Calculation of Dilutive Loss Per Share

The following table summarizes the Company’s securities, in common share equivalents, that have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive:

	As of September 30,
	2020		2019
Preferred stock		201,501,000,000		201,501,000,000
Stock options		68,062,000,000		91,062,000,000
Warrants		-		41,420,000,000
Total		269,563,000,000		333,983,000,000